In today's rapidly evolving technological landscape, the intersection between regulation and innovation is a critical space. Desiree Sainthrope, a legal expert with a focus on global compliance and technology, offers her insights into the ongoing debate over AI regulation in the U.S. The discussion
Desiree Sainthrope is no stranger to the intricacies of global trade agreements and compliance issues. A legal expert with an insightful view on privacy laws and their impact on business operations, she brings her wealth of knowledge to an increasingly relevant topic: the intersections of
Desiree Sainthrope is a distinguished legal expert known for her vast contributions to drafting trade agreements and her insights into global compliance standards. Her expertise extends into areas like intellectual property and the intricate implications of emerging technologies such as AI. In
The EU-US Data Privacy Framework (DPF) stands at the center of ongoing discussions about transatlantic data transfers amidst rapidly evolving global conditions. This framework plays a crucial role in maintaining the flow of data between the EU and the US, directly affecting thousands of companies
Recent developments in European Union regulations have precipitated a significant transformation within the clinical trial sector, especially regarding the integration of artificial intelligence. These regulatory changes present both challenges and opportunities for the biopharma industry,
In today's discussion, we're thrilled to have Desiree Sainthrope, a renowned legal expert in global compliance and trade agreements, who also holds a keen interest in the intersection of technology, such as AI, and law. Her insights are invaluable as we delve into the intricacies of AI regulations
